30 min listen
The Promise of Individualized HIV Prevention: Future Formulations and Dosing Intervals for Long-Acting PrEP
The Promise of Individualized HIV Prevention: Future Formulations and Dosing Intervals for Long-Acting PrEP
ratings:
Length:
18 minutes
Released:
Oct 21, 2021
Format:
Podcast episode
Description
In this episode, Nicholas Chamberlain, MD, provides an overview of the different antiretroviral drug formulations and dosing strategies in various stages of clinical development for long-acting HIV PrEP—advances that collectively offer the potential for highly individualized approaches to HIV biomedical prevention.Presenter:Nicholas Chamberlain, MDMedical DirectorAHF Healthcare Center – Atlanta MidtownDepartment of MedicineAIDS Healthcare FoundationAtlanta, GeorgiaContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program:https://bit.ly/3AFvsZY
Released:
Oct 21, 2021
Format:
Podcast episode
Titles in the series (100)
Addressing Age-Related Comorbidities Among People With HIV: Hear insights from Dr. Daniel Kuritzkes and Dr. Christian Ramers on preventing ART-associated bone loss, reducing cardiovascular disease risk, and managing HIV-associated neurocognitive disorders in this case-based discussion of comorbidity management and ART selection for aging patients with HIV. by CCO Infectious Disease Podcast